Fr. 188.00

Platelet Pharmacology and Therapy - Volume 5

Inglese · Copertina rigida

Pubblicazione il 01.09.2025

Descrizione

Ulteriori informazioni

This series consisting of five specific volumes will provide a detailed, up-to-date, well-referenced review for clinicians on recent developments in this rapidly expanding field. It will serve as an authoritative guide to the diagnosis and therapies of diseases involving platelets. The target readership of the series will primarily be clinicians, residents and fellows in Internal medicine, cardiology and haematology as well as clinical (e.g. neurologists, nephrologists, rheumatologists) and basic scientists who may deal with disorders and cellular mechanisms that involve platelets.

Sommario

Chapter 106: Aspirin.- Chapter 107: P2Y12 inhibitors.- Chapter 108: GPIIb/IIIa antagonists.- Chapter 109: PAR antagonists.- Chapter 110: PDE-adenosine reuptake-inhibitor agents.- Chapter 111: Nitric oxide-releasing or enhancing agents.- Chapter 112: Platelet puringeric receptors as targets for novel anti-inflammatory drugs.- Chapter 113: Novel approaches to antiplatelet therapy.- Chapter 114: Antiplatelet therapy in coronary artery disease.- Chapter 115: Antiplatelet therapy for TIA/stroke.- Chapter 116: Antiplatelet therapy for PAD.- Chapter 117: Laboratory monitoring-guided antiplatelet therapy.- Chapter 118: Antiplatelet therapy for venous thromboembolism.- Chapter 119: Platelets in regenerative medicine.- Chapter 120: Platelet transfusions.- Chapter 121: TPO agonists and agents under development to increase platelet count.- Chapter 122: In vitro generated  engineered or enhanced platelets.- Chapter 123: Platelets for gene therapy.- Chapter 124: Platelets as carriers for antitumor therapy.

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.